All

Vaping for Good Health?

by C. Scott McMillin | Sep 19, 2022 | In the News | 0 |

Marketed as supplements, they're excused from having to inform us. And they don't.

The Juul Ban

by C. Scott McMillin | Jul 11, 2022 | Addictive Substances | 0 |
Does Vaping Help People Quit Smoking?

by C. Scott McMillin | Dec 9, 2021 | Addictive Substances | 0 |
That Vaping Thing

by C. Scott McMillin | Nov 15, 2021 | Addictive Substances | 0 |
That Cannabis Study

by C. Scott McMillin | Nov 8, 2021 | Addiction | 0 |
Cleaning Up the Mess

by C. Scott McMillin | Jul 22, 2021 | Public Policy | 0 |

Vaping Reaches the Big Time

by C. Scott McMillin | Sep 24, 2020 | Addictive Substances, Resources | 0 |

Compared to a Marlboro, a Newport, or a Camel (the three most popular US brands), a vape pen may carry more nicotine to the lungs, with greater impact.

Selling Vaping

by C. Scott McMillin | May 25, 2020 | In the News | 0 |

By now the vaping industry has established a customer base that includes millions of young people – exactly the group they swore would never be targeted.

First Person: Vape Addicted

by C. Scott McMillin | Mar 12, 2020 | Addiction | 1 |

The nicotine is often more concentrated and it could actually be easier to get hooked, the way crack seems to produce addiction more readily than the cocaine it’s made from.

A Move to Regulate Vaping

by C. Scott McMillin | Mar 2, 2020 | Public Policy | 0 |

These businesses, many of them small shops, may have aggressively marketed these products for commercial reward.

The Ad Biz

by C. Scott McMillin | Dec 9, 2019 | Public Health | 0 |

Advertising is vulnerable to abuse. Rules are few and easy to circumvent.

The Vape Ban That Wasn’t

by C. Scott McMillin | Dec 5, 2019 | Addictive Substances, Public Policy | 0 |

Corporations will fight dirty if necessary to protect their investment. That includes in the political arena.

Can Legal Cannabis Fix Vaping Illness?

by C. Scott McMillin | Nov 7, 2019 | Public Health, Thinking About Addiction | 0 |

Legalization solves problems related to the legal status of a drug, but has far less impact on the problems related to the nature of the substance itself.